Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elakkiya, Munusamy"'
Autor:
Yamuna Devi Bakthavatchalam, Ravikar Ralph, Balaji Veeraraghavan, Priyanka Babu, Elakkiya Munusamy
Publikováno v:
Infectious Diseases and Therapy, Vol 8, Iss 1, Pp 51-62 (2018)
Abstract Introduction Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia may result in clinical failure of vancomycin therapy, together with prolonged infection and hospitalization. This clinical problem has resulted in
Externí odkaz:
https://doaj.org/article/09d6e925d9714b778e38762a46c134db
Autor:
Yamuna Devi Bakthavatchalam, Priyanka Babu, Elakkiya Munusamy, Hariharan Triplicane Dwarakanathan, Priscilla Rupali, Marcus Zervos, Peter John Victor, Balaji Veeraraghavan
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0227009 (2019)
Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important clinical concern in patients, and is often associated with significant disease burden and metastatic infections. There is an increasing evidence of heterogeneous vancomycin-
Externí odkaz:
https://doaj.org/article/c822805fe090453186651323dee8189e
Autor:
Jennifer L, Balaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Elakkiya Munusamy, Triplicane Dwarakanathan H
Publikováno v:
Microbial Drug Resistance. 25:413-420
Staphylococcal surface protein sasX is a colonization mediating virulence factor in ST239 methicillin-resistant Staphylococcus aureus (MRSA) strains, which potentially contribute to its successful establishment. We aimed to study the presence and dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f43dd7a51189123eb5457f5d3d6a77
https://doi.org/10.1089/mdr.2018.0292
https://doi.org/10.1089/mdr.2018.0292
Autor:
Elakkiya Munusamy, Balaji Veeraraghavan, Karthick Vasudevan, Priyanka Babu, Yamuna Devi Bakthavatchalam
Publikováno v:
International Journal of Infectious Diseases, Vol 101, Iss, Pp 331-(2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc87ee79c3f307e1b3bb3bfeb908a6f
http://www.sciencedirect.com/science/article/pii/S1201971220315848
http://www.sciencedirect.com/science/article/pii/S1201971220315848
Autor:
Elakkiya Munusamy, Priyanka Babu, Ravikar Ralph, Yamuna Devi Bakthavatchalam, Balaji Veeraraghavan
Publikováno v:
Infectious Diseases and Therapy
Infectious Diseases and Therapy, Vol 8, Iss 1, Pp 51-62 (2018)
Infectious Diseases and Therapy, Vol 8, Iss 1, Pp 51-62 (2018)
Introduction Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia may result in clinical failure of vancomycin therapy, together with prolonged infection and hospitalization. This clinical problem has resulted in a search
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::299a559b6c20a89932cda8795b4d619f
http://europepmc.org/articles/PMC6374240
http://europepmc.org/articles/PMC6374240
Autor:
Peter John Victor, Priscilla Rupali, Marcus J. Zervos, Balaji Veeraraghavan, Hariharan Triplicane Dwarakanathan, Elakkiya Munusamy, Yamuna Devi Bakthavatchalam, Priyanka Babu
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 12, p e0227009 (2019)
PLoS ONE, Vol 14, Iss 12, p e0227009 (2019)
Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important clinical concern in patients, and is often associated with significant disease burden and metastatic infections. There is an increasing evidence of heterogeneous vancomycin-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7311c52034f692fb9bd3c76af36ca609
http://europepmc.org/articles/PMC6936811
http://europepmc.org/articles/PMC6936811
Autor:
Raji Ravi, C.G.P. Doss, D.T. Kumar, Iftikhar Aslam Tayubi, Priyanka Babu, Balaji Veeraraghavan, B. Thukkaram, Elakkiya Munusamy, Baby Abirami Shankar, Yamuna Devi Bakthavatchalam
Publikováno v:
Journal of Applied Microbiology. 123:615-624
Aims Recently, the cefixime-ofloxacin combination is approved by drug controller general of India (DCGI) to treat typhoid fever. We sought to evaluate the antimicrobial activity of cefixime-ofloxacin combination against S. Typhi. Methods and Results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6706993db4f7232da13e8b5beb9449c8
https://doi.org/10.1111/jam.13522
https://doi.org/10.1111/jam.13522
Autor:
Chaitra, Shankar, Laura Eb, Nabarro, Shalini, Anandan, Raji, Ravi, Priyanka, Babu, Elakkiya, Munusamy, Visali, Jeyaseelan, Priscilla, Rupali, Valsan P, Verghese, Balaji, Veeraraghavan
Publikováno v:
The Journal of the Association of Physicians of India. 66(12)
Infections caused by carbapenem resistant K. pneumoniae are increasing and associated with high mortality rates. There are increasing reports of hypermucoviscous/ hypervirulent K. pneumoniae isolated from various sources. However, there is limited da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e12024c900c509a59d3d4d9997dc0466
https://pubmed.ncbi.nlm.nih.gov/31313543
https://pubmed.ncbi.nlm.nih.gov/31313543
Autor:
Naveen Kumar, Devanga Ragupathi, Dhiviya Prabaa, Muthuirulandi Sethuvel, Baby Abirami, Shankar, Elakkiya, Munusamy, Shalini, Anandan, Balaji, Veeraraghavan
Publikováno v:
Journal of global antimicrobial resistance. 7
Enteric fever is a major cause of concern in developing countries across the globe. The primary choice of antibiotics remains fluoroquinolones, followed by cephalosporins. Resistance to third-generation cephalosporins is rarely reported in Salmonella
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7034e5701f671c02ea649a9a8a2b9d56
https://pubmed.ncbi.nlm.nih.gov/27530999
https://pubmed.ncbi.nlm.nih.gov/27530999
Autor:
Dhiviya Prabaa Muthuirulandi Sethuvel, Shalini Anandan, Balaji Veeraraghavan, Naveen Kumar Devanga Ragupathi, Baby Abirami Shankar, Elakkiya Munusamy
Publikováno v:
Journal of Global Antimicrobial Resistance. 7:11-12
Enteric fever is a major cause of concern in developing countries across the globe. The primary choice of antibiotics remains fluoroquinolones, followed by cephalosporins. Resistance to third-generation cephalosporins is rarely reported in Salmonella
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31faac6ed6a784e52d65ea71b4f7ccef
https://doi.org/10.1016/j.jgar.2016.06.003
https://doi.org/10.1016/j.jgar.2016.06.003